Applied Genetic Technologies Corporation is currently in a long term downtrend where the price is trading 16.9% below its 200 day moving average.

From a valuation standpoint, the stock is 95.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 58.0.

Applied Genetic Technologies Corporation's total revenue sank by 100.0% to $0 since the same quarter in the previous year.

Its net income has dropped by 79.3% to $-15M since the same quarter in the previous year.

Finally, its free cash flow fell by 57.4% to $-14M since the same quarter in the previous year.

Based on the above factors, Applied Genetic Technologies Corporation gets an overall score of 1/5.